Non-invasive heart mapping for congenital heart disease
Part of Genetic & congenital, Heart & circulation clinical trials.
This trial tests a new, non-invasive way to create detailed 3D maps of the heart's electrical activity in people with congenital heart disease. It aims to help guide procedures like heart catheterization or device implantation, potentially making them safer and more personalized.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a congenital heart condition (a heart problem you were born with).
- Your doctor plans to do a catheter procedure to map your heart or to implant a device (like a pacemaker).
- You are 18 years old or older.
- You can stand upright for a few minutes for a 3D scan of your body.
- You are not pregnant or breastfeeding.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial is testing a way to help doctors assess babies and children with congenital heart disease and heart failure before placing a temporary heart support pump. It may help improve planning by using heart scans to decide who needs support and how to prepare.
This study tests how well your heart pumps during exercise while you are undergoing a heart catheter procedure. It may help doctors better understand your heart function and guide your treatment.
This study uses MRI scans and computer simulations to learn more about how the heart and blood flow work in people with certain heart or lung conditions. It may help researchers better understand heart problems and improve future care.
This study evaluates a new way to analyze heart function using a standard cardiac MRI scanner. If you have heart disease and need a heart MRI anyway, this trial tests whether this new analysis method works well across different hospitals and MRI machines.
This trial tests whether a special noninvasive heart “mapping” test done on the body can help improve outcomes for people who need a CRT device. It studies whether mapping before implantation can better guide or predict how well the CRT will work.
This trial tests a new heart-mapping technique to help doctors treat a fast heart rhythm caused by heart disease. It might improve the precision of the procedure, making it safer and more effective for patients with this condition.
Hear when a new Congenital Heart Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.